Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Sjogren’s syndrome
•
Neurology
•
Neuro-immunology
What is your initial treatment paradigm for someone with both CNS and peripheral neurologic Sjogren’s?
Related Questions
What is the role of skin biopsy for evaluating small fiber neuropathy in patients with rheumatic disease who have treatment recalcitrant pain?
Should IVIG dosing in patients with autoimmune disease (i.e., dermatomyositis) who become pregnant continue to be based on actual weight at the time of each infusion, or should it be limited to pre-pregnancy weight?
What is the role of inebilizumab in the maintenance treatment of IgG4-related disease?
What are your vaccine recommendations while patients are on biologics?
In a patient with strong serologic evidence of SLE presenting with isolated bilateral lower limb sensorimotor neuropathy, normal neuroimaging, and CSF, would you initiate cyclophosphamide with pulse-dose steroids upfront, or reserve escalation (e.g., plasma exchange or immunosuppressants) for cases refractory to steroids?
Do you consider immunosuppression in patients with a history of Sjogren's disease and clinical features of inclusion body myositis?
How do you decide on long term immunosuppression therapy for Susac Syndrome?
When do you obtain nerve biopsy to evaluate for vasculitic neuropathy in patients with distal symmetric polyneuropathies?
How do you counsel women on anti-CD20 therapy for MS who are planning for pregnancy?
What is the stepwise investigation of patients suspected of inflammatory myopathy?
